Premium
Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages
Author(s) -
Chedeville Annick,
Mirossay Ladislav,
Chastre Eric,
Hurbain-Kosmath Ilse,
Lopez Manuel,
Gespach Christian
Publication year - 1993
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/0014-5793(93)80061-x
Subject(s) - vasoactive intestinal peptide , adenylate kinase , receptor , cyclase , chemistry , endocrinology , pituitary adenylate cyclase activating peptide , retinoic acid , medicine , microbiology and biotechnology , biology , biochemistry , neuropeptide , gene
The activation of the cAMP signaling pathway by vasoactive intestinal peptide (VIP), pituitary adenylate cyclase‐activating peptide (PACAP) and related peptides was studied (i) in normal peripheral human monocytes and THP‐1 leukemic human monocytes, (ii) in their derived macrophage counterparts respectively obtained after spontaneous differentiation or retinoic acid (RA) treatment, and (iii) in human bronchoalveolar macrophages. In THP‐1 monocytes, PACAP increased basal adenylate cyclase activity 5.3‐fold, with an affinity 50‐times greater than that of VIP or helodermin ( K a = 3.2 × 10 −11 M VIP), whereas in normal peripheral monocytes, PACAP and VIP exhibited similar affinities and only increased eAMP generation 2‐fold (EC 50 = 10 −9 M). Spontaneous and RA‐induced differentiation into normal and leukemic macrophages induced a progressive loss of cAMP production and regulation of superoxide anion production by VIP and related peptides. The neoplastic transformation in THP‐1 monocytes and the deficiencies in the cAMP cascade observed during the terminal differentiation of normal and leukemic human macrophages may relate to a differential genetic expression of the VIP/PACAP receptor subtypes, and alterations in the functional activity of the stimulatory and inhibitory G s /G i subunits of adenylate cyclase.